GO
Loading...

RESEARCH ALERT-UBS cuts Idenix price target

Friday, 12 Oct 2012 | 7:27 AM ET

Oct 12 (Reuters) - :

* UBS cuts Idenix price target to $9 from $10

* UBS raises Celgene price target to $82 from $80

* UBS raises Biogen price target to $160 from $156 For a summary of rating and price target changes on U.S. companies:

Reuters Eikon users, click on

Reuters 3000Xtra users, double-click

Reuters Station users, click .1568

For a summary of rating and price target changes on Canadian companies:

Reuters Eikon users, click on

Reuters 3000Xtra users, double-click

Reuters Station users, click .4899

((Bangalore Newsroom; +1 646 223 8780))

  Price   Change %Change
CELG
---